TY - GEN AU - SouĂȘtre,E AU - Qing,W TI - Economic analysis of lenograstim in the correction of neutropenia following chemotherapy for non-Hodgkin's lymphoma SN - 1170-7690 PY - 1995///1129 KW - Adjuvants, Immunologic KW - economics KW - Adolescent KW - Adult KW - Antineoplastic Combined Chemotherapy Protocols KW - adverse effects KW - Chemotherapy, Adjuvant KW - Double-Blind Method KW - Female KW - France KW - Granulocyte Colony-Stimulating Factor KW - Hospitalization KW - Humans KW - Lenograstim KW - Lymphoma, Non-Hodgkin KW - complications KW - Male KW - Middle Aged KW - Neutropenia KW - chemically induced KW - Prospective Studies KW - Recombinant Proteins N1 - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't UR - https://doi.org/10.2165/00019053-199400062-00007 ER -